Biopharma Business

Tag "Type 2 Diabetes"

FDA approves Bydureon BCise for patients with type-2 diabetes

    FDA approves Bydureon BCise for patients with type-2 diabetes

The FDA has approved Bydureon BCise for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines. AstraZeneca has announced that the US Food and Drug Administration

Read Full Article

French Biotech Could Be Taking its Diabetes Drug to Phase III on its own

Poxel was able to score positive results for its type 2 diabetes drug in a Phase IIb study in Japan, preparing the company to go for a Phase III program. Poxel, one of

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements